Literature DB >> 29579256

Characterization of the Neutralizing Antibody Response in a Case of Genetically Linked HIV Superinfection.

Deogratius Ssemwanga1, Nicole A Doria-Rose2, Andrew D Redd3,4, Andrea R Shiakolas2, Andrew F Longosz3, Rebecca N Nsubuga1, Billy N Mayanja1, Gershim Asiki1, Janet Seeley1,5, Anatoli Kamali1, Amy Ransier2, Samuel Darko2, Michael P Walker6, Daniel Bruno6, Craig Martens6, Daniel Douek2, Stephen F Porcella6, Thomas C Quinn3,4, John R Mascola2, Pontiano Kaleebu1,5.   

Abstract

This report describes the identification of a genetically confirmed linked heterosexual human immunodeficiency virus (HIV) superinfection (HIV-SI) in a woman with chronic HIV infection who acquired a second strain of the virus from her husband. Serum neutralizing antibody (NAb) responses against their homologous and heterologous viruses, including the superinfecting strain, in the woman and her husband were examined before and after onset of HIV-SI. The woman displayed a moderately potent and broad anti-HIV NAb response prior to superinfection but did not possess NAb activity against the superinfecting strain. This case highlights the unique potential of linked HIV-SI studies to examine natural protection from HIV infection.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29579256      PMCID: PMC6065500          DOI: 10.1093/infdis/jiy071

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine design.

Authors:  Mattia Bonsignori; David C Montefiori; Xueling Wu; Xi Chen; Kwan-Ki Hwang; Chun-Yen Tsao; Daniel M Kozink; Robert J Parks; Georgia D Tomaras; John A Crump; Saidi H Kapiga; Noel E Sam; Peter D Kwong; Thomas B Kepler; Hua-Xin Liao; John R Mascola; Barton F Haynes
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

2.  Lack of neutralizing antibody response to HIV-1 predisposes to superinfection.

Authors:  Davey M Smith; Matthew C Strain; Simon D W Frost; Satish K Pillai; Joseph K Wong; Terri Wrin; Yang Liu; Christos J Petropolous; Eric S Daar; Susan J Little; Douglas D Richman
Journal:  Virology       Date:  2006-09-07       Impact factor: 3.616

3.  Identification of HIV superinfection in seroconcordant couples in Rakai, Uganda, by use of next-generation deep sequencing.

Authors:  Andrew D Redd; Aleisha Collinson-Streng; Craig Martens; Stacy Ricklefs; Caroline E Mullis; Jordyn Manucci; Aaron A R Tobian; Ethan J Selig; Oliver Laeyendecker; Nelson Sewankambo; Ronald H Gray; David Serwadda; Maria J Wawer; Stephen F Porcella; Thomas C Quinn
Journal:  J Clin Microbiol       Date:  2011-06-22       Impact factor: 5.948

4.  Timing and source of subtype-C HIV-1 superinfection in the newly infected partner of Zambian couples with disparate viruses.

Authors:  Colleen S Kraft; Debby Basu; Paulina A Hawkins; Peter T Hraber; Elwyn Chomba; Joseph Mulenga; William Kilembe; Naw H Khu; Cynthia A Derdeyn; Susan A Allen; Olivier Manigart; Eric Hunter
Journal:  Retrovirology       Date:  2012-03-20       Impact factor: 4.602

5.  The probable source of both the primary multidrug-resistant (MDR) HIV-1 strain found in a patient with rapid progression to AIDS and a second recombinant MDR strain found in a chronically HIV-1-infected patient.

Authors:  Gary Blick; Ron M Kagan; Eoin Coakley; Christos Petropoulos; Laura Maroldo; Paola Greiger-Zanlungo; Scott Gretz; Trish Garton
Journal:  J Infect Dis       Date:  2007-03-21       Impact factor: 5.226

6.  The general population cohort in rural south-western Uganda: a platform for communicable and non-communicable disease studies.

Authors:  Gershim Asiki; Georgina Murphy; Jessica Nakiyingi-Miiro; Janet Seeley; Rebecca N Nsubuga; Alex Karabarinde; Laban Waswa; Sam Biraro; Ivan Kasamba; Cristina Pomilla; Dermot Maher; Elizabeth H Young; Anatoli Kamali; Manjinder S Sandhu
Journal:  Int J Epidemiol       Date:  2013-01-30       Impact factor: 7.196

Review 7.  Frequency and implications of HIV superinfection.

Authors:  Andrew D Redd; Thomas C Quinn; Aaron A R Tobian
Journal:  Lancet Infect Dis       Date:  2013-05-31       Impact factor: 25.071

8.  Measuring HIV neutralization in a luciferase reporter gene assay.

Authors:  David C Montefiori
Journal:  Methods Mol Biol       Date:  2009

9.  HIV-1 superinfection occurs less frequently than initial infection in a cohort of high-risk Kenyan women.

Authors:  Keshet Ronen; Connor O McCoy; Frederick A Matsen; David F Boyd; Sandra Emery; Katherine Odem-Davis; Walter Jaoko; Kishor Mandaliya; R Scott McClelland; Barbra A Richardson; Julie Overbaugh
Journal:  PLoS Pathog       Date:  2013-08-29       Impact factor: 6.823

10.  HIV-1 superinfection in women broadens and strengthens the neutralizing antibody response.

Authors:  Valerie Cortez; Katherine Odem-Davis; R Scott McClelland; Walter Jaoko; Julie Overbaugh
Journal:  PLoS Pathog       Date:  2012-03-29       Impact factor: 6.823

View more
  3 in total

1.  Immune Correlates of Disease Progression in Linked HIV-1 Infection.

Authors:  Michael Tuen; Jude S Bimela; Andrew N Banin; Shilei Ding; Gordon W Harkins; Svenja Weiss; Vincenza Itri; Allison R Durham; Stephen F Porcella; Sonal Soni; Luzia Mayr; Josephine Meli; Judith N Torimiro; Marcel Tongo; Xiaohong Wang; Xiang-Peng Kong; Arthur Nádas; Daniel E Kaufmann; Zabrina L Brumme; Aubin J Nanfack; Thomas C Quinn; Susan Zolla-Pazner; Andrew D Redd; Andrés Finzi; Miroslaw K Gorny; Phillipe N Nyambi; Ralf Duerr
Journal:  Front Immunol       Date:  2019-05-14       Impact factor: 7.561

2.  Accurate Prediction for Antibody Resistance of Clinical HIV-1 Isolates.

Authors:  Reda Rawi; Raghvendra Mall; Chen-Hsiang Shen; S Katie Farney; Andrea Shiakolas; Jing Zhou; Halima Bensmail; Tae-Wook Chun; Nicole A Doria-Rose; Rebecca M Lynch; John R Mascola; Peter D Kwong; Gwo-Yu Chuang
Journal:  Sci Rep       Date:  2019-10-11       Impact factor: 4.379

3.  Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants.

Authors:  Lingshu Wang; Tongqing Zhou; John Misasi; Yi Zhang; Eun Sung Yang; Chaim A Schramm; Wei Shi; Amarendra Pegu; Olamide K Oloniniyi; Amy R Henry; Samuel Darko; Sandeep R Narpala; Christian Hatcher; David R Martinez; Yaroslav Tsybovsky; Emily Phung; Olubukola M Abiona; Avan Antia; Evan M Cale; Lauren A Chang; Misook Choe; Kizzmekia S Corbett; Rachel L Davis; Anthony T DiPiazza; Ingelise J Gordon; Sabrina Helmold Hait; Tandile Hermanus; Prudence Kgagudi; Farida Laboune; Kwanyee Leung; Tracy Liu; Rosemarie D Mason; Alexandra F Nazzari; Laura Novik; Sarah O'Connell; Sijy O'Dell; Adam S Olia; Stephen D Schmidt; Tyler Stephens; Christopher D Stringham; Chloe Adrienna Talana; I-Ting Teng; Danielle A Wagner; Alicia T Widge; Baoshan Zhang; Mario Roederer; Julie E Ledgerwood; Tracy J Ruckwardt; Martin R Gaudinski; Penny L Moore; Nicole A Doria-Rose; Ralph S Baric; Barney S Graham; Adrian B McDermott; Daniel C Douek; Peter D Kwong; John R Mascola; Nancy J Sullivan
Journal:  Science       Date:  2021-07-01       Impact factor: 63.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.